Membranous glomerulopathy in a patient on captopril.

This case report describes a patient with essential hypertension in whom captopril during seven months resulted in a nephrotic syndrome. A renal biopsy specimen revealed membranous glomerulopathy stage I. After withdrawal of the drug, urinary protein loss disappeared within ten days. However, a second biopsy three months later still showed granular deposition of IgA, IgG, IgM and C3 in the glomerular basement membrane and unchanged subepithelial electron-dense deposits on electron microscopy. Glomerular filtration rate remained normal during the observation period.

[1]  J. Weening,et al.  IMMUNE-COMPLEX GLOMERULOPATHY IN PATIENTS TREATED WITH CAPTOPRIL , 1980, The Lancet.

[2]  R. Ritz,et al.  CAPTOPRIL-ASSOCIATED AGRANULOCYTOSIS , 1980, The Lancet.

[3]  Y. Seedat.  APHTHOUS ULCERS OF MOUTH FROM CAPTOPRIL , 1979, The Lancet.

[4]  J. Weening,et al.  SERUM-SICKNESS-LIKE SYNDROME WITH MEMBRANOUS GLOMERULOPATHY IN PATIENT ON CAPTOPRIL , 1979, The Lancet.

[5]  P. Vlasses,et al.  TEMPORARY AGEUSIA RELATED TO CAPTOPRIL , 1979, The Lancet.

[6]  C. Johnston,et al.  LONG-TERM EFFECTS OF CAPTOPRIL (SQ14 225) ON BLOOD-PRESSURE AND HORMONE LEVELS IN ESSENTIAL HYPERTENSION , 1979, The Lancet.

[7]  J. Weening,et al.  NEPHROTIC SYNDROME IN PATIENT ON , 1979, The Lancet.

[8]  J. Laragh,et al.  Interruption of the Renin‐Angiotensin System in Hypertensive Patients by Captopril Induces Sustained Reduction in Aldosterone Secretion, Potassium Retention and Natriuresis , 1979, Hypertension.

[9]  N. Hollenberg,et al.  Converting Enzyme Inhibition in Essential Hypertension: The Hypotensive Response Does Not Reflect Only Reduced Angiotensin II Formation , 1979, Hypertension.

[10]  S. Oparil,et al.  Mechanism of Angiotensin I Converting Enzyme Inhibition by SQ20,881 ( , 1979, Hypertension.

[11]  E. J. Prins.  Converting-enzyme inhibition experiences with captopril in hypertensive patients , 1979 .

[12]  P. Cotton.  Endoscopic treatnent of biliary-tract diseases. , 1979, Lancet.

[13]  B. Hökfelt,et al.  The effect of the converting enzyme inhibitor SQ 20.881 on kinins, renin-angiotensin-aldosterone and catecholamines in relation to blood pressure in hypertensive patients. , 2009, Acta medica Scandinavica.

[14]  J. Laragh,et al.  Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients. , 1978, Progress in cardiovascular diseases.

[15]  H. Gavras,et al.  Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man. , 1978, The New England journal of medicine.

[16]  M. Woldring,et al.  Special problems in the radioimmunoassay of plasma aldosterone without prior extraction and purification. , 1978, Clinica chimica acta; international journal of clinical chemistry.

[17]  A. Donker,et al.  A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow. , 1977, The Netherlands journal of medicine.

[18]  C. Ruckley,et al.  A 5 year follow up of lords dilation for hemorrhoids , 1976 .

[19]  G. Edwards.  THE ALCOHOLIC DOCTOR A Case of Neglect , 1975, The Lancet.

[20]  Barr Jb,et al.  HEALTH VISITING AND GENERAL PRACTICE. , 1964 .